Skip to content

Antigen Rapid Test for SARS-CoV-2 (COVID-19) Antibody Detection (Serum/Plasma)

Published: August 9, 2026Updated: August 16, 2026

This test detects antibodies in your blood that your immune system produces in response to exposure to the virus that causes COVID-19. It helps determine if you may have been previously infected.

Quick summary

["This test checks for immune system response to COVID-19, not current infection status."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
112078-1
Short code
FLUABV + SARS-CoV-2 Ag Nose Ql IA.rapid
Synonyms
FLUABV + SARS-CoV-2 Ag Nose Ql IA.rapid
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
ia-rapid
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

How the Test Works

The test uses a rapid immunoassay method to identify specific antibodies (immunoglobulins) in your serum or plasma. These antibodies are produced by your immune system after exposure to the SARS-CoV-2 virus. The test detects antibodies that bind to viral proteins, indicating a past infection.

What to Expect Before the Test

No special preparation is needed. You may have blood drawn from a vein in your arm, or a small sample may be collected via fingerstick. The test is typically performed on a small blood sample taken during a routine blood draw or at a testing site.

What the Test Results Mean

A positive result suggests you may have been previously infected with COVID-19 and developed antibodies. A negative result means the test did not detect antibodies at this time, but it does not rule out past infection. False negatives can occur, especially if tested too soon after exposure.

Limitations and Considerations

This test is a screening tool and may not detect all types of antibodies. It is not a diagnostic test for current COVID-19 infection. Results can vary based on the timing of testing after exposure and the individual’s immune response.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

COVID-19 Antibody Screen (Rapid)

Frequently asked questions

Why might I need this test?
This test can help determine if you have developed immunity after recovering from COVID-19 or if you have been exposed to the virus in the past. It may be used for monitoring, research, or certain workplace or travel-related requirements.
What does a positive result mean?
A positive result indicates the presence of antibodies that your immune system produced in response to the virus. This suggests you likely had COVID-19 at some point, but it does not confirm the exact timing or severity of infection. Antibody levels may decrease over time.
Can I get COVID-19 again if this test is positive?
While a positive antibody test suggests past exposure, it does not guarantee immunity against future infection. COVID-19 can reoccur, and immunity may vary among individuals. Consult your healthcare provider for guidance on protection and vaccination status.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy